Exane BNP Paribas upgraded Healthpeak to Neutral from Underperform with a $19 price target.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PEAK:
- Bad News for Healthpeak Properties, Inc. Stock: This New Risk Has Been Added
- Healthpeak Properties Unveils Q4 and Full Year Financials
- Healthpeak files automatic mixed securities shelf
- Healthpeak sees FY24 adjusted FFO $1.73-$1.79, consensus $1.81
- Healthpeak reports Q4 adjusted FFO 46c, consensus 45c